We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Quantitative Molecular Test Improves Diagnosis of Brucellosis

By LabMedica International staff writers
Posted on 02 Nov 2011
Rapid diagnosis of individuals infected with brucellosis can sometimes be difficult with conventional microbiological techniques.

The diagnostic yield of a real-time polymerase chain reaction (rt-PCR) assay during an outbreak of brucellosis supported the rapid identification of the causative organism. More...


Microbiologists at the Carlos Haya University Hospital (Malaga, Spain) compared the rt-PCR with conventional microbiological methods for diagnosing brucellosis in a family outbreak of brucellosis due to consumption of unpasteurized goat cheese. Two blood culture sets, a quantitative rt- PCR assay in serum, Rose Bengal test, standard agglutination test (SAT), and immunocapture–agglutination test were performed for all the patients with suspected Brucella infection. In patients exposed but asymptomatic, only serology and real-time PCR were performed.

Blood cultures were positive in three of the eight symptomatic cases and all of them identified as Brucella melitensis biovar 3. The Rose Bengal test result was positive in seven of the symptomatic subjects. SAT and the immunocapture-agglutination test result had titers within the diagnostic range for six patients. SAT and the immunocapture–agglutination test results were positive but showed titers below the diagnostic range in the remaining two cases and in both asymptomatic subjects.

The PCR amplifications were performed in capillary tubes with a LightCycler instrument (Roche Diagnostic; San Cugat del Valles, Spain) using primers obtained from Tib-Molbiol (Berlin, Germany). Each assay was performed using a standard curve of genomic B. melitensis DNA (2 × 105 genome copies per 2 mL DNA extract) and negative controls (water). The rt-PCR was positive in all subjects who became ill and negative in those who did not develop symptoms.

The authors concluded that quantitative rt-PCR could be a useful tool for the rapid diagnosis of persons involved in outbreaks of brucellosis due to occasional consumption of unpasteurized milk or cheese. However, it is possible that this technology will have no practical use for handling outbreaks in occupationally exposed subjects, and studies are needed to determine its usefulness in outbreaks affecting laboratory workers. The study was published in the November 2011 edition of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Carlos Haya University Hospital
Roche Diagnostic
Tib-Molbiol




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.